Machine learning predicts the short-term requirement for invasive ventilation among Australian critically ill COVID-19 patients.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
21
12
2021
accepted:
07
10
2022
entrez:
26
10
2022
pubmed:
27
10
2022
medline:
29
10
2022
Statut:
epublish
Résumé
To use machine learning (ML) to predict short-term requirements for invasive ventilation in patients with COVID-19 admitted to Australian intensive care units (ICUs). A machine learning study within a national ICU COVID-19 registry in Australia. Adult patients who were spontaneously breathing and admitted to participating ICUs with laboratory-confirmed COVID-19 from 20 February 2020 to 7 March 2021. Patients intubated on day one of their ICU admission were excluded. Six machine learning models predicted the requirement for invasive ventilation by day three of ICU admission from variables recorded on the first calendar day of ICU admission; (1) random forest classifier (RF), (2) decision tree classifier (DT), (3) logistic regression (LR), (4) K neighbours classifier (KNN), (5) support vector machine (SVM), and (6) gradient boosted machine (GBM). Cross-validation was used to assess the area under the receiver operating characteristic curve (AUC), sensitivity, and specificity of machine learning models. 300 ICU admissions collected from 53 ICUs across Australia were included. The median [IQR] age of patients was 59 [50-69] years, 109 (36%) were female and 60 (20%) required invasive ventilation on day two or three. Random forest and Gradient boosted machine were the best performing algorithms, achieving mean (SD) AUCs of 0.69 (0.06) and 0.68 (0.07), and mean sensitivities of 77 (19%) and 81 (17%), respectively. Machine learning can be used to predict subsequent ventilation in patients with COVID-19 who were spontaneously breathing and admitted to Australian ICUs.
Identifiants
pubmed: 36288359
doi: 10.1371/journal.pone.0276509
pii: PONE-D-21-40262
pmc: PMC9604987
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0276509Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Chest. 2021 Feb;159(2):524-536
pubmed: 33069725
Nat Mach Intell. 2020 Jan;2(1):56-67
pubmed: 32607472
J Clin Epidemiol. 2019 Jun;110:63-73
pubmed: 30878639
Crit Care. 2021 Mar 25;25(1):121
pubmed: 33766109
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
J Clin Epidemiol. 2006 Oct;59(10):1102-9
pubmed: 16980151
Med J Aust. 2020 Nov;213(10):439-441.e2
pubmed: 33111999
Anesthesiology. 2020 Jun;132(6):1307-1316
pubmed: 32195699
Lancet Respir Med. 2021 Apr;9(4):349-359
pubmed: 33444539
PLoS One. 2021 Apr 1;16(4):e0249285
pubmed: 33793600
Sci Rep. 2016 Jul 22;6:30086
pubmed: 27444562
J Crit Care. 2021 Apr;62:25-30
pubmed: 33238219
Sci Rep. 2021 Feb 18;11(1):4200
pubmed: 33603086
Eur J Clin Microbiol Infect Dis. 2020 Jul;39(7):1379-1389
pubmed: 32337662
Med J Aust. 2021 Jan;214(1):23-30
pubmed: 33325070
N Engl J Med. 2020 Dec 17;383(25):2451-2460
pubmed: 32412710
BMC Bioinformatics. 2006 Feb 23;7:91
pubmed: 16504092
Crit Care Explor. 2021 Jan 22;3(1):e0329
pubmed: 33521646
BMJ Qual Saf. 2019 Oct;28(10):778-781
pubmed: 31147420
PLoS One. 2017 Apr 4;12(4):e0174944
pubmed: 28376093
PLoS One. 2020 Apr 24;15(4):e0232391
pubmed: 32330208
Environ Sci Pollut Res Int. 2020 Oct;27(29):37155-37163
pubmed: 32700269
PLoS One. 2020 Nov 12;15(11):e0239172
pubmed: 33180787
Med J Aust. 2020 Jun;212(10):472-481
pubmed: 32356900
Signal Transduct Target Ther. 2021 Apr 24;6(1):165
pubmed: 33895786